Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Cardiovascular Medicine

Background:

• Early onset preeclampsia (EOP) is a pregnancy disorder with complex thrombotic and bleeding risks.
• Understanding the hemostatic balance in EOP is crucial for managing patient outcomes.

Purpose of the Study:

• To characterize thrombin generation in patients with EOP.
• To elucidate the hemostatic balance in EOP by assessing thrombin generation dynamics.

Main Methods:

• Calibrated automated thrombography was employed to assess thrombin generation in EOP patients.
• Plasma samples from EOP patients were compared to non-pregnant and pregnant controls.
• Tissue factor pathway inhibitor (TFPI) activity was measured in EOP patients.

Main Results:

• Thrombin generation triggered by low-dose tissue factor (TF) was significantly reduced in EOP patients, especially in severe cases.
• EOP patients showed a trend towards increased response to activated protein C and thrombomodulin.
• Elevated plasma TFPI activity was observed in EOP patients, and TFPI inhibition reversed the reduced thrombin generation.

Conclusions:

• EOP is characterized by attenuated coagulation, specifically reduced thrombin generation stimulated by low-dose TF.
• Increased plasma TFPI activity contributes to the coagulation abnormalities in EOP.
• These hemostatic alterations may play a role in modulating thrombotic and bleeding risks in EOP.